loading page

Case Report of Chronic Eosinophilic Leukemia Associated with Long-Term Use of Infliximab
  • William Morse,
  • Haroon Nawaz,
  • Ayesha Choudhry
William Morse
Ross University School of Medicine

Corresponding Author:[email protected]

Author Profile
Haroon Nawaz
Westside Regional Medical Center
Author Profile
Ayesha Choudhry
Fatima Jinnah Medical University
Author Profile


We present a patient who has been diagnosed with Hypereosinophilic syndrome, later determined to be chronic eosinophilic leukemia, after long-term treatment with infliximab for ulcerative colitis. Follow-up immunochemistry showed that discontinuation of infliximab improved the polyclonality of eosinophils in our patient.
17 Jan 2022Submitted to Clinical Case Reports
03 Oct 2022Assigned to Editor
03 Oct 2022Submission Checks Completed
03 Oct 2022Reviewer(s) Assigned
08 Oct 2022Review(s) Completed, Editorial Evaluation Pending
08 Oct 2022Editorial Decision: Revise Minor